Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Feb 25, 2026

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Feb 28, 2026

Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan - Sarepta Therapeutics

Sarepta Therapeutics - Feb 24, 2026

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance

Yahoo Finance - Feb 11, 2026

Sarepta Therapeutics Announces Approval of Clinical Trial Application for SRP-1005, Its Investigational Treatment for Huntington’s Disease - Sarepta Therapeutics

Sarepta Therapeutics - Feb 04, 2026

Sarepta Therapeutics, Inc. (SRPT): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Sarepta Therapeutics Announces Third Quarter 2025 Financial Results and Recent Corporate Developments, Including Completion of Its Confirmatory Study, ESSENCE - Sarepta Therapeutics

Sarepta Therapeutics - Nov 03, 2025

Sarepta Therapeutics to Report 3-Year Topline Data from EMBARK Study of ELEVIDYS Gene Therapy in Ambulatory Individuals with Duchenne Muscular Dystrophy - Yahoo Finance

Yahoo Finance - Jan 23, 2026

Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53® - Sarepta Therapeutics

Sarepta Therapeutics - Mar 19, 2026

Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Yahoo Finance - Jan 05, 2026

Sarepta Therapeutics Applauds Addition of Duchenne Muscular Dystrophy to the U.S. Recommended Uniform Screening Panel (RUSP) - Sarepta Therapeutics

Sarepta Therapeutics - Dec 17, 2025

Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report? - Yahoo Finance

Yahoo Finance - Dec 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment